Prenetics Global Limited (PRENW)
USD 0.01
(1.02%)
USD 0.01
(1.02%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 867.21 Thousand USD | -76.96% |
| 2022 | 3.76 Million USD | 4.53% |
| 2021 | 3.6 Million USD | 347.47% |
| 2020 | 804.57 Thousand USD | -10.56% |
| 2019 | 899.54 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | 669.37 Thousand USD | 0.0% |
| 2023 Q3 | 3.06 Million USD | -5.92% |
| 2023 FY | 867.21 Thousand USD | -76.96% |
| 2023 Q4 | 867.21 Thousand USD | -71.69% |
| 2023 Q2 | 3.25 Million USD | -10.26% |
| 2023 Q1 | 3.62 Million USD | -3.6% |
| 2022 Q2 | 3.06 Million USD | -5.41% |
| 2022 Q1 | 3.24 Million USD | -9.94% |
| 2022 Q4 | 3.76 Million USD | 51.21% |
| 2022 FY | 3.76 Million USD | 4.53% |
| 2022 Q3 | 2.48 Million USD | -18.85% |
| 2021 FY | 3.6 Million USD | 347.47% |
| 2021 Q1 | 586.34 Thousand USD | -27.12% |
| 2021 Q3 | 434.26 Million USD | 21.26% |
| 2021 Q4 | 3.6 Million USD | -99.17% |
| 2021 Q2 | 358.13 Million USD | 60980.41% |
| 2020 Q4 | 804.57 Thousand USD | 0.0% |
| 2020 FY | 804.57 Thousand USD | -10.56% |
| 2019 FY | 899.54 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aspira Women's Health Inc. | 1.43 Million USD | 39.356% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | 22.464% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -966.37% |
| Standard BioTools Inc. | 3.98 Million USD | 78.227% |
| Inotiv, Inc. | 399.4 Million USD | 99.783% |
| Neuronetics, Inc. | 59.28 Million USD | 98.537% |
| Star Equity Holdings, Inc. | 1.14 Million USD | 24.261% |
| Castle Biosciences, Inc. | 14.19 Million USD | 93.892% |
| Psychemedics Corporation | 945 Thousand USD | 8.231% |
| RadNet, Inc. | 812.06 Million USD | 99.893% |
| Exact Sciences Corporation | 2.47 Billion USD | 99.965% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 99.861% |
| iSpecimen Inc. | 29.13 Thousand USD | -2877.051% |
| OpGen, Inc. | 2.02 Million USD | 57.103% |
| Exagen Inc. | 19.23 Million USD | 95.491% |
| Bionano Genomics, Inc. | 7.17 Million USD | 87.913% |
| CareDx, Inc | 28.27 Million USD | 96.933% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 79.17 Million USD | 98.905% |
| Guardant Health, Inc. | 1.13 Billion USD | 99.924% |
| Biodesix, Inc. | 35.22 Million USD | 97.538% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -778.077% |
| Precipio, Inc. | 106 Thousand USD | -718.127% |
| Natera, Inc. | 282.94 Million USD | 99.694% |
| Fulgent Genetics, Inc. | 10.11 Million USD | 91.423% |
| Sera Prognostics, Inc. | 840 Thousand USD | -3.24% |
| 23andMe Holding Co. | 67.84 Million USD | 98.722% |
| OPKO Health, Inc. | 222.03 Million USD | 99.609% |
| Personalis, Inc. | 1.23 Million USD | 29.723% |
| Aclaris Therapeutics, Inc. | 3.07 Million USD | 71.789% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -17.324% |
| T2 Biosystems, Inc. | 6.59 Million USD | 86.856% |
| Neogen Corporation | 888.39 Million USD | 99.902% |
| Myriad Genetics, Inc. | 130.9 Million USD | 99.337% |
| ICON Public Limited Company | 3.66 Billion USD | 99.976% |
| NeoGenomics, Inc. | 606.06 Million USD | 99.857% |
| Star Equity Holdings, Inc. | 1.14 Million USD | 24.261% |
| MDxHealth SA | 35.56 Million USD | 97.562% |
| Prenetics Global Limited | 867.21 Thousand USD | 0.0% |
| Illumina, Inc. | 1.48 Billion USD | 99.942% |
| DarioHealth Corp. | 24.59 Million USD | 96.473% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -351.529% |
| Medpace Holdings, Inc. | 142.12 Million USD | 99.39% |
| Mainz Biomed B.V. | 2.19 Million USD | 60.507% |
| Trinity Biotech plc | 54.65 Million USD | 98.413% |
| Sotera Health Company | 2.22 Billion USD | 99.961% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | 22.464% |